Liminatus Pharma, Inc. Class A Common Stock
LIMNHealthcare|Biotechnology|US
$2.54
-0.09 (-3.42%)
Tangible Book / Share
$0.63
Cash / Share
$6.35
Ownership Breakdown
35.3%
Float
1.3M
Shares Outstanding
0.5M
Float Shares
Major Holders (11)
Combined: 112.9%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Iris Acquisition Holdings LLC | Other | 26.50% | 6,900,000 | May 8, 2025 | 13D/G |
| KH Feelux Co., Ltd | Corporation | 15.40% | 4,000,000 | Jun 27, 2025 | 13D/G |
| Chris Kim | Individual | 14.30% | 9,617,954 | Jul 14, 2026 | 13D/G |
| Valetudo Therapeutics LLC | Partnership | 14.30% | 9,617,954 | Jul 14, 2026 | 13D/G |
| Ewon Comfortech Co., Ltd. | Corporation | 10.90% | 5,500,000 | Jul 6, 2026 | 13D/G |
| Nongae Apple Association 1st | Other | 5.70% | 1,470,000 | Jun 26, 2025 | 13D/G |
| Red Peony Association 1st | Other | 5.70% | 1,470,000 | Jun 26, 2025 | 13D/G |
| Samda Biolab Co., Ltd. | Corporation | 5.10% | 3,426,548 | Jul 22, 2026 | 13D/G |
| Mitchell P. Kopin | HC, IN | 4.99% | 2,065,885 | Feb 20, 2026 | 13D/G |
| Daniel B. Asher | HC, IN | 4.99% | 2,065,885 | Feb 20, 2026 | 13D/G |
| Intracoastal Capital LLC | Other | 4.99% | 2,065,885 | Feb 20, 2026 | 13D/G |
Insider Trades (16)
Last 4 quarters: 0 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Valetudo Therapeutics LLC | 10 percent owner | Jul 2, 2026 | J | 3,448,926 | $0.20 | $689.8K | Form 4 |
| Valetudo Therapeutics LLC | 10 percent owner | Jun 24, 2026 | DISPOSED | 4,373,603 | — | — | Form 4 |
| Ewon Comfortech Co., Ltd. | 10 percent owner | Jun 24, 2026 | OTHER | 0 | — | — | Form 4 |
| Iris Acquisition Holdings LLC | 10 percent owner | Apr 30, 2025 | OTHER | 0 | — | — | Form 4 |
| Lemons II Philip Wayne | director: | Jul 10, 2025 | OTHER | 0 | — | — | Form 4 |
| Baek Richard JaiHwan | director: | Jul 10, 2025 | OTHER | 0 | — | — | Form 4 |
| KH Feelux Co., Ltd | 10 percent owner | Apr 30, 2025 | OTHER | 0 | — | — | Form 4 |
| Valetudo Therapeutics LLC | 10 percent owner | Apr 30, 2025 | OTHER | 0 | — | — | Form 4 |
| Lee Eun Sook | director: | Apr 30, 2025 | OTHER | 0 | — | — | Form 4 |
| Baek Ji Yeon | director: | Apr 30, 2025 | OTHER | 0 | — | — | Form 4 |
| Kim Chris | director, 10 percent owner, officer: Chief Executive Officer | Apr 30, 2025 | OTHER | 0 | — | — | Form 4 |
| Choi Beom Kyu | officer | Apr 30, 2025 | OTHER | 0 | — | — | Form 4 |
| Yoo Byong Chul | officer | Apr 30, 2025 | OTHER | 0 | — | — | Form 4 |
| Lee Sang-Jin | officer | Apr 30, 2025 | OTHER | 0 | — | — | Form 4 |
| Fernandez Nicholas | director: | Apr 30, 2025 | OTHER | 0 | — | — | Form 4 |
| Dam Scott | officer | Apr 30, 2025 | OTHER | 0 | — | — | Form 4 |